Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
11/2000
11/16/2000WO2000042191A3 Neisseria meningitidis antigenic polypeptides, corresponding polynucleotides and protective antibodies
11/16/2000WO2000042179A3 Complex-forming proteins
11/16/2000WO2000041717A3 Chorionic gonadotropin dna vaccines and methods
11/16/2000WO2000041477A3 Production of heterologous proteins from zygosaccharomyces bailii
11/16/2000WO2000040709A3 Process for altering plant synthesis in plants using modified trnas
11/16/2000WO2000039287A3 A. fumigatus acetyl coenzyme-a carboxylase genes and polypeptides and uses thereof
11/16/2000WO2000039285A3 Human glycosylphosphatidylinositol specific phospholipase d variants and uses thereof
11/16/2000WO2000037652A3 Flavonoid biosynthetic enzymes
11/16/2000WO2000037639A3 Lymphocytic membrane proteins
11/16/2000WO2000037613A3 Human akt-3
11/16/2000WO2000037025A3 Antibodies to truncated vegf-d and uses thereof
11/16/2000WO2000036119A3 Plant phosphatidylinositol metabolism proteins
11/16/2000WO2000036118A3 HUMAN CYCLIN-DEPENDENT KINASE (hPNQALRE)
11/16/2000WO2000036110A3 Plant disease resistance genes
11/16/2000WO2000034784A9 Protein scaffolds for antibody mimics and other binding proteins
11/16/2000WO2000034511A3 Aβ-PEPTIDE SCREENING ASSAY
11/16/2000WO2000034493A3 Regulatory sequences of the mouse villin gene - use in transgenesis
11/16/2000WO2000034468A3 Muc-1 antagonists and methods of treating immune disorders
11/16/2000WO2000032814A3 Methods for producing selected interstrand cross-links in nucleic acids and applications thereof
11/16/2000WO2000032796A3 Kinetoplastid protein expression system
11/16/2000WO2000032790A3 Membrane-bound desaturases
11/16/2000WO2000032765A3 Ribozyme therapy for the treatment and/or prevention of restenosis
11/16/2000WO2000031305A3 Primer extension methods utilizing donor and acceptor molecules for detecting nucleic acids
11/16/2000WO2000031237A3 Method of cloning porcine animals
11/16/2000WO2000029603A3 Low cost manufacture of oligosaccharides
11/16/2000WO2000029592A3 Chimeric promoters capable of mediating gene expression in plants upon pathogen infection and uses thereof
11/16/2000WO2000029561A3 Nucleotide construct with optimised codons for an hiv genetic vaccine based on a primary, early hiv isolate and synthetic envelope
11/16/2000WO2000029012A3 Methods of alleviating cancer symptoms
11/16/2000WO2000028032A3 Human cell surface receptor proteins
11/16/2000WO2000026370A3 Adenine nucleotide translocator (ant) fusion proteins and uses thereof
11/16/2000WO2000026247A3 Ikaros isoforms and mutants
11/16/2000WO2000026241A3 Novel compositions and methods of screening for t-cell and b-cell activation modulators
11/16/2000WO2000025578A3 Methods for cloning animals
11/16/2000WO2000024907A3 Library of novel "unnatural" natural products
11/16/2000WO2000023621A3 Visualization of rna in living cells
11/16/2000WO2000023466A3 Human rna binding proteins
11/16/2000WO2000023464A3 Zinc finger binding domains for gnn
11/16/2000WO2000022439A3 Method and substances for diagnosis and therapy of sepsis and sepsis-like systemic infections
11/16/2000WO2000022110A3 Targeted proteolysis by recruitment to ubiquitin protein ligases
11/16/2000WO2000022095A9 Method and apparatus for direct in vivo gene transfer by electrotransfection
11/16/2000WO2000020615A3 Commercial production of laccase in plants
11/16/2000WO2000020448A3 Nlk1 -interacting proteins
11/16/2000WO2000018916A3 Human genes and gene expression products
11/16/2000WO2000009706A3 Maize cellulose synthases and uses thereof
11/16/2000WO2000009549A3 Peripheral-type benzodiazepine receptor associated proteins, cloning, expression and methods of use
11/16/2000WO2000007631A9 Expression and characterization of hiv-1 envelope protein associated with a broadly reactive neutralizing antibody response
11/16/2000WO2000007432A9 Biodegradable high oxidative stability oils
11/16/2000WO2000006717A9 Improved transformation efficiency in phage display through modification of a coat protein
11/16/2000WO2000005375A9 Gbs toxin receptor
11/16/2000WO2000001838A3 Methods for making polyketides
11/16/2000WO2000001713A3 Diacylglycerol acyl transferase proteins
11/16/2000WO1999051186A3 Methods and compositions for the diagnosis and treatment of neuropsychiatric disorders
11/16/2000DE19949579C1 Microorganism with deregulated cysteine metabolism, useful for high-level production of cysteine and its derivatives, has increased activity of the CysB transcription regulator
11/16/2000DE19922407A1 Preparing medicament for treating viral infections, liver diseases or cancer, comprising recombinant parapoxvirus targeted towards specific organs, cells or tissues
11/16/2000DE19920514A1 Methoden zur Auffindung von Proteasen, die spezifisch membrangebundene Substrate spalten Methods for the detection of proteases that cleave specific membrane-bound substrates
11/16/2000DE19919225A1 Tumorassoziiertes Antigen Tumor-associated antigen
11/16/2000DE10012670A1 Isolation of metaphase chromosomal material comprises chromosomal microdissection after hybridizing fluorescence-labeled DNA probes to the target material
11/16/2000CA2721199A1 Isolating biological modulators from biodiverse gene fragment libraries
11/16/2000CA2384338A1 Infectivity-enhanced conditionally-replicative adenovirus and uses thereof
11/16/2000CA2374237A1 Compositions and methods for identifying antigens which elicit an immune response
11/16/2000CA2373851A1 Nucleic acid-antibody conjugate for delivering a foreign nucleic acid in cells
11/16/2000CA2373759A1 Serine proteases
11/16/2000CA2373672A1 Method for controlling the fidelity and execution of reverse transcriptase by incorporating and polymerising nucleotide analogues acceptable as substrates without blocking its elongation
11/16/2000CA2373631A1 Monoclonal antibody directed against cells of human renal cell carcinoma
11/16/2000CA2373617A1 Compositions and methods for improving learning and memory
11/16/2000CA2373550A1 Methods of identifying therapeutic compounds in a genetically defined setting
11/16/2000CA2373507A1 Prp-like gene
11/16/2000CA2373135A1 Novel thermostable alkaliphilic xylanase
11/16/2000CA2373121A1 Vector-mediated delivery of integrating transposon sequences
11/16/2000CA2373063A1 Death domain containing receptor 4
11/16/2000CA2373061A1 Diagnosis of primary congenital glaucoma
11/16/2000CA2372993A1 Diagnosis of glaucoma
11/16/2000CA2372983A1 Recombinant penicillium funiculosum for homologous and heterologous protein production
11/16/2000CA2372968A1 Whole cell assay for cathepsin k
11/16/2000CA2372902A1 Rad51-like orthologues and uses thereof
11/16/2000CA2372881A1 Novel nucleic acids and proteins with p53 activity and altered tetramerization domains
11/16/2000CA2372871A1 Novel nucleic acids and proteins with growth hormone activity
11/16/2000CA2372854A1 Identification of candida albicans essential fungal specific genes and use thereof in antifungal drug discovery
11/16/2000CA2372837A1 Cytokine receptor mouse zcytor10
11/16/2000CA2372823A1 Combinatorial metabolic libraries
11/16/2000CA2372821A1 Antimicrobial theta defensins and methods of using same
11/16/2000CA2372815A1 Extracellular matrix and adhesion-associated proteins
11/16/2000CA2372805A1 Autotaxin variants and uses to treat diseases of metabolism
11/16/2000CA2372735A1 Assay reagent
11/16/2000CA2372699A1 Methods for treating tumors using antiangiogenic compounds
11/16/2000CA2372687A1 Phytyl/prenyltransferase nucleic acids, polypeptides and uses thereof
11/16/2000CA2372635A1 A process of cell reprogramming through production of a heterokaryon
11/16/2000CA2372597A1 Human gabab receptor 1 promoters
11/16/2000CA2372593A1 Methods for constructing dna library and support carrying dna library immobilized thereon
11/16/2000CA2372585A1 Method of culturing cells
11/16/2000CA2372515A1 Recombinant platelet collagen receptor glycoprotein vi and its pharmaceutical use
11/16/2000CA2371902A1 Novel nucleic acids and proteins with interferon-beta activity
11/16/2000CA2371843A1 Multiple tag analysis
11/16/2000CA2371279A1 Recombinant vaccine against botulinum neurotoxin
11/16/2000CA2371195A1 Cells and assays
11/16/2000CA2371193A1 Family of immunoregulators designated leukocyte immunoglobulin-like receptors (lir)
11/16/2000CA2370512A1 Soybean homolog of disease resistance factor coi1
11/16/2000CA2370212A1 Methods of discovering proteases which specifically cleave membrane-bound substrates
11/16/2000CA2370027A1 Seed specific promoters
11/16/2000CA2370017A1 Plant defensins
1 ... 3155 3156 3157 3158 3159 3160 3161 3162 3163 3164 3165 3166 3167 3168 3169 3170 3171 3172 3173 3174 3175 ... 4023